Stereotactic body radiotherapy/stereotactic ablative body radiotherapy for lung cancer

Hua Ren, Shanda Blackmon, Bin S. Teh

Research output: Chapter in Book/Report/Conference proceedingChapter


Technological advances in radiation oncology have led to clinical implementation of novel treatment modality. Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) is an emerging treatment paradigm as a result of image-guidance technology and more sophisticated computational treatment planning system. SBRT/SABR, an example of computational radiosurgery, is a continuum of advances in computational surgery. The role of SBRT/SABR is most important in the management of lung cancer for early primary lung cancer and in oligometastatic lung disease. SBRT/SABR combines the challenges of patient/tumor/normal tissues motion with that of meeting the stringent dosimetric requirements of stereotactic radiosurgery (SRS). Target delineation, image guidance, patient immobilization, computer-assisted treatment planning, and delivery are essential in the safe and successful practice of SBRT/SABR. Radio-biologic rationale, technical and clinical aspects of SBRT/SABR in the treatment of both primary and metastatic lung cancer as well as the future challenges will be addressed.

Original languageEnglish (US)
Title of host publicationComputational Surgery and Dual Training
Subtitle of host publicationComputing, Robotics and Imaging
PublisherSpringer New York
Number of pages20
ISBN (Electronic)9781461486480
ISBN (Print)9781461486473
StatePublished - Jan 1 2014


  • Cardiopulmonary disease
  • Computational treatment planning
  • Computer-assisted treatment
  • Lung cancer
  • Metastatic cancer
  • Radiation oncology
  • Radiotherapy
  • Stereostatic system
  • Thoracic surgery
  • Tumor ablation

ASJC Scopus subject areas

  • Engineering(all)


Dive into the research topics of 'Stereotactic body radiotherapy/stereotactic ablative body radiotherapy for lung cancer'. Together they form a unique fingerprint.

Cite this